Results 101 to 110 of about 34,187 (225)

EANM position on the in-house preparation of radiopharmaceuticals [PDF]

, 2022
Harry Hendrikse, Oliver Kiss, Jolanta Kunikowska, Wolfgang Wadsak, Clemens Decristoforo, Marianne Patt   +5 more
openalex   +1 more source

Associations Between Growth Differentiating Factor‐15 and Frailty in Older Adults From the MAPT Study

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Frailty is a prevalent syndrome in older adults and is associated with increased vulnerability to adverse health outcomes. Growth differentiation factor 15 (GDF‐15), a cytokine involved in mitochondrial dysfunction and inflammation, has been proposed as a potential biomarker for age‐related conditions.
Juan Luis Sánchez‐Sánchez, Yves Rolland, Alexandre Lucas, Sophie Guyonnet, Bruno Vellas, Philipe de Souto Barreto, for the MAPT/DSA Group   +6 more
wiley   +1 more source

Therapeutic Effects of Noninvasive Electrical Stimulation in Combination Transplantation of Human Adipose‐Derived Stem Cells‐Derived Dopaminergic Neuron on the Monkey Model of Parkinson's Disease

MedComm, Volume 7, Issue 2, February 2026.
Our results showed that noninvasive electrical stimulation (NES) alone or in combination with human adipose‐derived stem cells (hADSCs)‐induced dopaminergic neuron (NES‐DN) improved the behavioral deficits and pathological features of the MPTP‐induced PD monkey model.
Chunhui Huang, Shane Gao, Xiao Zheng, Xichen Song, Jiaxi Wu, Kai Liao, Jiawei Li, Yingqi Lin, Caijuan Li, Yaqun Lu, Jiahao Feng, Huiyi Wei, Lu Wang, Hao Xu, Wei Wang, Yizhi Chen, Jianhao Wu, Jiale Gao, Junzhu Song, Chunxiang Shi, Jun Zhang, Sen Yan   +21 more
wiley   +1 more source

Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG‐1901 Study

Cancer Science, Volume 117, Issue 2, Page 501-510, February 2026.
The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota, Shuichi Tatarano, Tomomi Kamba, Toshiyuki Kamoto, Tsukasa Igawa, Naoya Masumori, Hirotsugu Uemura, Kensuke Mitsunari, Takayuki Sumiyoshi, Hiroji Uemura, Katsuyoshi Higashijima, Shoji Tokunaga, Masatoshi Eto   +12 more
wiley   +1 more source

Research Progress of Microfluidics in Radiopharmaceutical Quality Control [PDF]

Zhenhao Dong, Qinggang He, Dilong Mao, Jing Wang, Hong Zhang   +4 more
openalex   +1 more source

Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform

Nature Communications
Effective antitumor nanomedicines maximize therapeutic efficacy by prolonging drug circulation time and transporting drugs to target sites. Although numerous nanocarriers have been developed for accurate tumor targeting, their limited water solubility ...
Wenjing Xie, Haoyu Wang, Huimin Xu, Wen Su, Ting Yuan, Jianqiao Chang, Yiqi Bai, Yixiao Fan, Yang Zhang, Yunchao Li, Xiaohong Li, Louzhen Fan   +11 more
doaj   +1 more source

18F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings

Angewandte Chemie, Volume 138, Issue 4, 22 January 2026.
A general Ni‐mediated (C)sp2–(C)sp3 cross‐coupling expedites access to 18F‐radiopharmaceuticals, essential for positron emission tomography imaging and drug discovery. This late‐stage diversification approach was implemented across three user‐friendly automated protocols affording 18F‐radiotracers in sufficient quantities for imaging.
Isabella F. Ogilvy, Joseph Ford, Sebastiano Ortalli, Evelien Renders, Thomas R. Hayes, Shuanglong Liu, Inne Mortiers, Anastasia Nikolopoulou, Alexandre M. Sorlin, Andrés A. Trabanco, Matthew Tredwell, Peter J. J. A. Buijnsters, Rhys Salter, Véronique Gouverneur   +13 more
wiley   +1 more source

Nano-radiopharmaceuticals as therapeutic agents

Frontiers in Medicine
In recent years, there has been an increased interest in exploring the potential synergy between nanotechnology and nuclear medicine. The application of radioactive isotopes, commonly referred to as radiopharmaceuticals, is recognized in nuclear medicine
Tanu Dixit, Nayomi Dave, Kausani Basu, Pranav Sonawane, Trutuja Gawas, Selvan Ravindran   +5 more
doaj   +1 more source

Development of a new class of radiopharmaceuticals for diagnosis and therapy of CXCR4-expressing malignancies based on the endogenous CXCR4 antagonist EPI-X4

, 2023
Raghuvir H. Gaonkar, Melpomeni Fani
openalex   +1 more source

Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine [PDF]

, 2023
Jean-Luc Urbain, Andrew M. Scott, Sze Ting Lee, John Buscombe, Charlotte Weston, Jun Hatazawa, Seigo Kinuya, Baljinder Singh, Mohamad Haidar, Andrew S. Ross, François Lamoureux, Jolanta Kunikowska, Wolfgang Wadsak, Rudi Dierckx, Diana Páez, Francesco Giammarile, Kyung-Han Lee, Joo Hyun O, Modiselle Moshe, Lizette Louw, Stuart More, Helen Nadel, Daniel Lee, Richard L. Wahl   +23 more
openalex   +1 more source